Member Info for Poidster

No one cares, until it happens to them or a loved one. Sickening really.

It's also putting enormous winter type pressures on the NHS but now it's year round.

No one gives a sh 1t

I'm surprised the SP has dropped this low and beginning to think that we haven't reached the bottom yet.

To improve things Novacyt need to start generating good, sustainable non covid revenue. It will come, in time.

I was tempted to average down a couple of months ago, glad I held off, still have the adage of 'a fool and his money..' ringing in my ears.

I saw green shoots in the agm presentation, its just going to take time. I've parked the covid aberration now, it was an opportunistic spike.

Now as a result of that, they have significantly more cash in bank and are debt free, which in these uncertain times, is a big tick.

The DHSC case will come to a resolution, I don't think its going to be a black and white win/lose, there will be compromise and I expect nyct will come out of it ok and DHSC will save a little face. Its normally the way of such things.

The PR seems to have improved markedly. If you take the covid episode out of the equation and 'pretend' it didn't happen, think back to where they were prior to it.

It's going to be a long haul and a plod.

This downtrend atm, doesn't make any sense, but when over the last 18 months had it made sense.

I'm going to sit it out & see what transpires.

Just an FYI, covid gone nowhere, killing 1000 -2000 extra per month but no one seems to care anymore. Its not going to raise anymore cash for nova that ship has sailed but funny what becomes acceptable to Joe Public if they don't know about it.

Just thought I'd pop by and say hi, don't check this board very often anymore, best of luck everyone, its only money, lots more important things to worry about.

Poidster out x

yet again 1 of my posts was deleted, I posted this under the the original thread, luckily enough, I've learned from previous experience, so I copied it and will post it again here below.
Just a few points to note, I don't have any insider info, I'm just expressing my own thoughts and opinions. If anyone sees fit to delete this post again, I will post it again, contact me directly if I'm over stepping a mark.
@larry I can't respond to your twitter post, so I'll say it on here.
I still stand by my original statement regarding this whole issue.
The genesig kit originally supplied was tested and assessed by the technical validation group and approved for use by the NHS themselves.
We also need to remember what the situation was like then in the UK.
Things were pretty dire, no high volume testing solutions were available. Novacyt provided a solution of sorts, not the high volume of traditional analysers but nonetheless better than other tests available at that time.
The efficacy and precision of their test was never in question, it was just labour intensive and was prone to USER error in a busy, microbiology environment.
So the test supplied was FIT FOR PURPOSE and approved by the NHS.
Novacyt took the usability issue on board and rapidly supplied PROmate which was much better suited to a busy general microbiology lab and removed most of the user errors.
I still to this day, don't understand the issue raised by the NHS.
Novacyt provided the approved genesis covid test in large quantities.
It needs to be paid for.
Another test was provided by Novacyt, at considerable cost to Novacyt to develop and provide.
The original genesig kit was thus rendered redundant.
It was all then shipped back to Novacyt and was I think given to WHO free of charge.
This still needs to be paid for. The kit supplied was approved and delivered.
If this is the situation that's in dispute, which I stress is just my opinion, I cannot understand whats in dispute.
Time will tell I guess

@BH beginning to think I should throw my hat into the ring, couldn't be any worse than DA

We don't need a ceo with a detailed knowledge of molecular diagnostics we already have plenty of staff capable to do that.
We need a ceo who understands the potential of the technology and can sell and persuade others and by dynamic and invigorating to go get out and sell novacyt to the world, extolling their virtues and what sets nova apart from its competitors,
DA was so so bad and the antithesis of whats needed. I still can't believe he got the job, over a year wasted.

@Larry all that sounds very promising thats why after the last DA presentation I was reasonably reassured.
The problem i have now is that none of those words are actually translating into actions.
And whilst nova seem to be treading water other players are filling those gaps.
There have been a few gilt edged opportunities that I personally thought were right up nova's Street but nothing seems to have happened.
They could have bid for those and been unsuccessful i suppose but I've not even heard on the grapevine anything about them bidding.
We've not had a positive, well worded RNS now since before GM left, at least 1 that resulted in an improved SP.
I want to hear of new sales and new markets and not from diligent PIs but from them.
Its like there's a total news blackout now and I don't know why.
Industry magazines are cover to cover now with near patient testing equipment. The world isn't standing still waiting for nova to get its act together.
Its just so frustrating, when I invested i invested in a dynamic, agile, cutting edge company. Because of their small but well skilled team they could react quickly to rapidly changing demands.
All thats gone now buried in a cloud of secrecy and inaction and for the life of me don't know why.
They need solid recurring, growing revenue, organic growth to coin a phrase,
I just see a rotting husk atm.
I'm not being negative per se, im just telling it how I see it now.
Not sure how much more jam tomorrow stuff i can swallow anymore.
BOD should be ashamed drawing a wage now

Its good to see some activity after such a long time of nothing.

Tbh it shouldn't need to be punters telling them what to do. They employ well paid ppl to do this. If they don't know what markets they should be targeting then nova is doomed. At the moment none of us have any idea what market they are going after. It would appear none to me.
But what do I know

Think I suggested this ages ago on here with the Strep A lft kits, its a growing market, globally but nothing seems to be happening

You heard about that too, didn't post about it because its not relevant to novacyt but there you go

Also hearing rumblings about a Lassa fever outbreak in West Africa (cat 4 pathogen, think Ebola) that is also progressing

In response to my post a few days earlier about no first mover opportunities, in a fast moving world things change quickly.
Influenza cases which are resulting in rapid death in humans are on the rise. Its thought to be a sub variant of the avian flu thats running rampant globally atm.
Watch this space

@neil re the biomedical scientist magazine.
This is what frustrates me so much its an emerging market (poc) and the methodologies that nova have could be adapted to sit in this space really well.
Theres growing momentum now to try to keep ppl out of hospital who don't really need to be there.
The NHS are now investing in telehealth, which means the patient can be monitored from home and cared for that way without the need for a hospital stay. If they start deteriorating, intervention happens quickly and, if necessary they are admitted, the hope is thou that the intervention happens early enough to prevent admission. Its a great idea imo as patients tend to do much better at home and aren't exposed to so many other diseases. I only think this market is going to grow.
Nova could help in this sphere and in community diagnostic hubs.
The problem for me is that I see no evidence whatsoever that they are actively targeting these markets. Its why I said in a previous post what market are they actually going after. As far as the UK goes, none of the above seems to be the answer.
I invested in this bloody company because I saw beyond the covid market and thought and still think that uts got potential but they need to do SOMETHING, as far as I can see they are doing nothing, at all, literally.
If they are then get out there and shout it from the rooftops.
I have absolutely no idea about their strategy, markets they are targeting and roadmaps for future developments.
Salad man said some things that reassured me slightly but he's either been sacked or left and now they just seem to be doing nothing. Years now are just passing by and nothing seems to be happening, it's getting on my nerves now, they need a massive kick up the ****

Fair point V1, I was basing my conjecturing ? On what I've seen and what I've heard, not what I know for fact.
Again in the absence of anything official, we will just have to wait and see. Hopefully we will be pleasantly surprised.
Sorry, didn't mean to come across as being overtly negative. Just a little frustrated as I see potential opportunities just slide by, maybe they're not, plus I know nothing about none UK markets

As far as I can see there's very little first mover opportunities atm, they are selling into a fulfilled market, even POC is getting crowded now.
Not sure selling loss leaders is viable.
They have already got loads of machines out in nhs labs in cupboards gathering dust.
If novacyt could be smart and suggest that these "free" machines could be deployed in different areas of healthcare, with community diagnostic hubs for instance and then sell their appropriate kits to meet an unfilled need.
Also, they appear to be doing very little active marketing and aren't knocking on doors how are users supposed to know the products exist

I just wish they would decide what their market is and go out and, you know, market the stuff they are making and sell some of it

In the absence of any info from the company Larry we just have to guess and speculate, less than ideal situation, again. Its almost like they are stuck in limbo until the DHSC issue is resolved, which in itself is bonkers since they are still selling into the NHS now.

Gave up trying to fathom where they are targeting a long time ago, hadnt made any sense to me now for a long time.

Well thats an unexpected development. Yet more privatisation of current NHS services.
NHS will just be a logo soon, the gov are selling off whats left of the NHS before they get booted out.
They've tried this before, it never ends very well.

@WBA, as ecstatic as I would be by that just cannot see that happening sadly